Why weight loss drugs aren’t solving NZ’s obesity problem
One man has been pushed into a risky, dangerous method of weight loss because of the cost.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
One man has been pushed into a risky, dangerous method of weight loss because of the cost.
Scientists at the University of California, Riverside have uncovered a surprising reason why males and females may respond differently to obesity. In a study involving mice, researchers discovered that immune cells traditionally associated with allergies and asthma can either protect against obesity-related inflammation or contribute to harmful metabolic cha
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.
<p>A landmark study proposes a new way to identify people whose excess body fat is affecting their health</p>
Healthcare providers say factors such as genetics, hormones and metabolism can make weight loss difficult despite efforts to adopt healthier lifestyles.
For a long time, the conversation about obesity came down to one number on the scale. That is starting to change. Almost a quarter of adults in the UAE, 22.4 per cent, are living with obesity, according to the Ministry of Health and Prevention’s National Health and Nutrition Survey 2024-2025. The same survey found that more than half of adults have high chol
Using data from more than 800,000 people, researchers have tested a system that can identify those with obesity who would benefit from treatment, and those who don't require intervention
A surprising study of more than 4,500 older adults found that people who were overweight or obese when diagnosed with dementia had a 16% to 27% lower risk of death than those at a normal weight. Researchers suspect that extra energy and muscle reserves may help patients survive the disease's toll on the body, although the reason for the survival advantage re
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
SEOUL, Nov. 3 (Yonhap) -- LG Chem Ltd., South Korea's leading chemical company, ...
<p>Cross-party committee says ‘moonshot’ vow to end obesity epidemic in a decade will fail without personal leadership from PM</p><p>The UK government’s promise to reverse rising obesity rates in the next decade is “doomed to fail” without a major rethink and a new plan led directly by the prime minister, a cross-party committee of MPs has concluded.</p><p>T
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Drugs like Mounjaro are not the only solution to problem
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.